Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy.

N Engl J Med

Division of Metabolism and Endocrinology Products, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.

Published: March 2010

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMp1001578DOI Listing

Publication Analysis

Top Keywords

weighing risks
4
risks benefits
4
benefits liraglutide--the
4
liraglutide--the fda's
4
fda's review
4
review antidiabetic
4
antidiabetic therapy
4
weighing
1
benefits
1
liraglutide--the
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!